Literature DB >> 16452543

Decreased soluble leptin receptor levels in women with polycystic ovary syndrome.

Susanne Hahn1, Uwe Haselhorst, Beate Quadbeck, Susanne Tan, Rainer Kimmig, Klaus Mann, Onno E Janssen.   

Abstract

OBJECTIVE: Polycystic ovary syndrome (PCOS) is associated with insulin resistance and a high incidence of obesity. Leptin, the product of the ob gene, is involved in the regulation of energy balance and obesity and circulates in both free and bound forms. The soluble leptin receptor (sOB-R) is the most important leptin-binding protein, thus influencing the biologically active free leptin level.
DESIGN: We assessed the correlation of metabolic and endocrine parameters with leptin and sOB-R levels in 122 PCOS women (aged 27 +/- 5.7 years) and 81 healthy controls (aged 25 +/- 4.0 years).
METHODS: Leptin and sOB-R levels were measured using ELISA kits. In addition, anthropometric variables, body fat and endocrine parameters were evaluated and a glucose tolerance test performed to assess indices of insulin resistance and glucose metabolism.
RESULTS: In PCOS patients, no correlation was found between leptin or sOB-R and parameters of hyper-androgenism. However, as expected, body mass index (BMI), body fat, waist circumference and indices of insulin resistance were significantly correlated with leptin in PCOS subjects and controls. In a subgroup analysis of lean, overweight and obese PCOS patients, significant differences were found in leptin (29.7 +/- 20.7 vs 45.4 +/- 25.0 vs 67.7 +/- 28.8 ng/ml, P < 0.0001) and sOB-R (8.0 +/- 3.4 vs 6.4 +/- 2.5 vs 5.7 +/- 2.3 ng/ml, P < 0.05). Compared with BMI-matched controls, lean PCOS patients had lower sOB-R levels (8.0 +/- 3.4 vs 12.7 +/- 4.7 ng/ml, P < 0.0001) and higher free leptin indices (4.5 +/- 3.9 vs 2.8 +/- 2.2, P = 0.0285).
CONCLUSION: Taking into account that low sOB-R levels supposedly compensate diminished leptin action, PCOS per se might cause leptin resistance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16452543     DOI: 10.1530/eje.1.02078

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  11 in total

1.  Obesity in children with congenital adrenal hyperplasia in the Minnesota cohort: importance of adjusting body mass index for height-age.

Authors:  Kyriakie Sarafoglou; Gregory P Forlenza; O Yaw Addo; Jennifer Kyllo; Aida Lteif; P C Hindmarsh; Anna Petryk; Maria Teresa Gonzalez-Bolanos; Bradley S Miller; William Thomas
Journal:  Clin Endocrinol (Oxf)       Date:  2017-03-28       Impact factor: 3.478

Review 2.  Cardiometabolic aspects of the polycystic ovary syndrome.

Authors:  Harpal S Randeva; Bee K Tan; Martin O Weickert; Konstantinos Lois; John E Nestler; Naveed Sattar; Hendrik Lehnert
Journal:  Endocr Rev       Date:  2012-07-24       Impact factor: 19.871

3.  Plasma leptin levels and risk of breast cancer in premenopausal women.

Authors:  Holly R Harris; Shelley S Tworoger; Susan E Hankinson; Bernard A Rosner; Karin B Michels
Journal:  Cancer Prev Res (Phila)       Date:  2011-06-16

4.  Environmental and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer remission and inhibition.

Authors:  Lei Cao; Xianglan Liu; En-Ju D Lin; Chuansong Wang; Eugene Y Choi; Veronique Riban; Benjamin Lin; Matthew J During
Journal:  Cell       Date:  2010-07-09       Impact factor: 41.582

5.  "Association of Leptin with Polycystic Ovary Syndrome: a Systematic Review and Meta-Analysis".

Authors:  Mahesh Kumar Seth; Sarthak Gulati; Shreya Gulati; Amit Kumar; Dimple Rawat; Aradhana Kumari; Rohini Sehgal; Rinchen Zangmo; Vivek Dixit; Arti Gulati
Journal:  J Obstet Gynaecol India       Date:  2021-08-04

6.  Association of leptin G2548A and leptin receptor Q223R polymorphisms and their serum levels with infertility and recurrent pregnancy loss in Iranian women with polycystic ovary syndrome.

Authors:  Fatemeh Bagheri Kargasheh; Soheila Ansaripour; Nasrin Borumandnia; Nariman Moradi; Zahra Zandieh; Monireh Maleki; Sara Mokhtar; Atousa Karimi; Farnaz Fatemi; Asma Kheirollahi; Akram Vatannejad
Journal:  PLoS One       Date:  2021-08-18       Impact factor: 3.240

Review 7.  Endocrine causes of nonalcoholic fatty liver disease.

Authors:  Laura Marino; François R Jornayvaz
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

8.  Impact of obesity on the risk for polycystic ovary syndrome.

Authors:  Bulent O Yildiz; Eric S Knochenhauer; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2007-10-09       Impact factor: 5.958

Review 9.  Polycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age Women.

Authors:  Dinka Pavicic Baldani; Lana Skrgatic; Roya Ougouag
Journal:  Int J Endocrinol       Date:  2015-06-01       Impact factor: 3.257

10.  Leptin as well as Free Leptin Receptor Is Associated with Polycystic Ovary Syndrome in Young Women.

Authors:  Nasser M Rizk; Elham Sharif
Journal:  Int J Endocrinol       Date:  2015-06-09       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.